PSYCHOSOCIAL PREDICTORS OF THE PLACEBO RESPONSE IN A RANDOMIZED CLINICAL TRIAL FOR MAJOR DEPRESSIVE DISORDER (MDD)

被引:0
|
作者
Tartter, Margaret A. [1 ]
Leuchter, Andrew F. [1 ]
Hunter, Aimee F. [1 ]
Cook, Ian A. [1 ]
机构
[1] Univ Calif Los Angeles, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:A121 / A121
页数:1
相关论文
共 50 条
  • [31] Vortioxetine Versus Placebo for Major Depressive Disorder: A Comprehensive Analysis of the Clinical Trial Dataset
    Iovieno, Nadia
    Papakostas, George, I
    Feeney, Anna
    Fava, Maurizio
    Mathew, Sanjay J.
    Iosifescu, Dan I.
    Murrough, James W.
    Macaluso, Matthew
    Hock, Rebecca S.
    Jha, Manish K.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2021, 82 (04)
  • [32] Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial
    Ventura, Daniel
    Armstrong, Edward P.
    Skrepnek, Grant H.
    Erder, M. Haim
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (02) : 245 - 250
  • [33] Impact of aripiprazole discontinuation in remitted major depressive disorder: a randomized placebo-controlled trial
    Takeshima, Masahiro
    Umakoshi, Akise
    Omori, Yuki
    Yoshizawa, Kazuhisa
    Ogasawara, Masaya
    Kudo, Mizuki
    Itoh, Yu
    Ayabe, Naoko
    Mishima, Kazuo
    [J]. PSYCHOPHARMACOLOGY, 2024, 241 (08) : 1555 - 1563
  • [34] Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial
    Mao, Jun J.
    Xie, Sharon X.
    Zee, Jarcy
    Soeller, Irene
    Li, Qing S.
    Rockwell, Kenneth
    Amsterdam, Jay D.
    [J]. PHYTOMEDICINE, 2015, 22 (03) : 394 - 399
  • [35] MRI predictors of pharmacotherapy response in major depressive disorder
    Gerlach, Andrew R.
    Karim, Helmet T.
    Pecina, Marta
    Ajilore, Olusola
    Taylor, Warren D.
    Butters, Meryl A.
    Andreescu, Carmen
    [J]. NEUROIMAGE-CLINICAL, 2022, 36
  • [36] Clinical predictors of suicide in primary major depressive disorder
    Coryell, W
    Young, EA
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (04) : 412 - 417
  • [37] Clinical evaluation of Major Depressive Disorder (MDD) and Borderline Personality Disorder(BPD) in youth adolescents
    Kaleda, V.
    Krylova, E.
    Kuleshov, A.
    Beburishvili, A.
    [J]. EUROPEAN PSYCHIATRY, 2022, 65 : S328 - S328
  • [38] Neuroimaging Genomics a Predictor of Major Depressive Disorder (MDD)
    Jindal, Manav
    Chhetri, Aakash
    Ludhiadch, Abhilash
    Singh, Paramdeep
    Peer, Sameer
    Singh, Jawahar
    Brar, Rahatdeep Singh
    Munshi, Anjana
    [J]. MOLECULAR NEUROBIOLOGY, 2024, 61 (06) : 3427 - 3440
  • [39] MAJOR DEPRESSIVE DISORDER (MDD) IN ESRD: AN IMPACTFUL COMORBIDITY
    Sundaresh, Shyam
    Meyer, B. Robert
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S505 - S505
  • [40] Neuropeptide Y and CRH in Major Depressive Disorder (MDD)
    Mathe, Aleksander A.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2013, 17 : 12 - 12